tiprankstipranks
Trending News
More News >
Ultralife (ULBI)
:ULBI
US Market
Advertisement

Ultralife (ULBI) Earnings Dates, Call Summary & Reports

Compare
159 Followers

Earnings Data

Report Date
Oct 23, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.21
Last Year’s EPS
0.02
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 07, 2025|
% Change Since: -2.66%|
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture, with significant revenue growth in the Battery & Energy Products segment and successful integration of Electrochem being positive aspects. However, the decline in Communication Systems revenue, challenges with tariffs, and lower gross margins presented notable challenges. Despite these issues, ongoing product development and debt reduction efforts provide optimism for future growth.
Company Guidance -
Q3 2025
During the second quarter of 2025, Ultralife Corporation reported sales of $48.6 million, up from $43 million in the same period last year. The company's operating income stood at $2.3 million, which included a onetime $0.3 million adjustment, while net profit was $0.9 million, translating to $0.05 EPS on a GAAP basis and $0.07 on an adjusted basis. The company faced challenges including a 57.2% decline in Communications Systems segment revenue and a 20.4% decrease in commercial sales, particularly in medical battery sales and oil and gas, due to order timing and macroeconomic and geopolitical factors. The gross profit remained flat at $11.6 million, with a consolidated gross margin of 23.9%, down from 26.9% the previous year, impacted by product mix, tariffs, and lower factory throughput. Operating expenses rose by 22.2% to $9.3 million due to increased investment in new product development and costs related to the Electrochem acquisition. The total backlog of high-confidence orders was $89 million, with an adjusted EBITDA of $4.1 million or 8.5% of sales, down from $5.4 million or 12.6% the previous year. The company successfully repaid over $0.7 million of its acquisition debt in Q2, ahead of schedule, and reduced its debt principal by $3.4 million in the first half of 2025.
Revenue Growth in Battery & Energy Products
Revenues from the Battery & Energy Products segment were $45.9 million, compared to $36.7 million last year, driven by a 61.1% increase in government defense sales.
Successful Integration of Electrochem
Successfully transitioned Electrochem's ERP and office systems to Ultralife systems in Q2, completing the main system transition and planning further integration in Q3.
Debt Reduction Progress
Reduced acquisition debt by $3.4 million in the first half of 2025, exceeding the $2.8 million amortization required for the full year.
New Product Developments
Expanded the ruggedizer server case portfolio and developed a 20-Watt amplifier for international markets with expected orders later this year.

Ultralife (ULBI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ULBI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 23, 2025
2025 (Q3)
0.21 / -
0.02
Aug 07, 2025
2025 (Q2)
0.13 / 0.05
0.18-72.22% (-0.13)
May 09, 2025
2025 (Q1)
- / 0.11
0.18-38.89% (-0.07)
Apr 01, 2025
2024 (Q4)
0.13 / 0.11
0.18-38.89% (-0.07)
Nov 08, 2024
2024 (Q3)
0.18 / 0.02
0.08-75.00% (-0.06)
Jul 25, 2024
2024 (Q2)
0.12 / 0.18
0.21-14.29% (-0.03)
Apr 25, 2024
2024 (Q1)
0.09 / 0.18
-0.021000.00% (+0.20)
Feb 15, 2024
2023 (Q4)
0.07 / 0.17
-0.011800.00% (+0.18)
Oct 26, 2023
2023 (Q3)
0.08 / 0.08
-0.01900.00% (+0.09)
Jul 27, 2023
2023 (Q2)
0.02 / 0.21
0.03600.00% (+0.18)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ULBI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 07, 2025
$8.16$6.77-17.03%
May 09, 2025
$4.88$5.05+3.48%
Apr 01, 2025
$5.38$5.05-6.13%
Nov 08, 2024
$9.28$7.98-14.01%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ultralife (ULBI) report earnings?
Ultralife (ULBI) is schdueled to report earning on Oct 23, 2025, Before Open (Confirmed).
    What is Ultralife (ULBI) earnings time?
    Ultralife (ULBI) earnings time is at Oct 23, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ULBI EPS forecast?
          ULBI EPS forecast for the fiscal quarter 2025 (Q3) is 0.21.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis